{"id":"https://openalex.org/W2163632142","doi":"https://doi.org/10.1053/euhj.1998.1093","title":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study","display_name":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study","alternate_titles":[],"publication_year":1998,"publication_date":"1998-10-01","ids":{"openalex":"https://openalex.org/W2163632142","doi":"https://doi.org/10.1053/euhj.1998.1093","mag":"2163632142","pmid":"https://pubmed.ncbi.nlm.nih.gov/9820995"},"language":"en","primary_location":{"id":"doi:10.1053/euhj.1998.1093","doi":"https://doi.org/10.1053/euhj.1998.1093","is_oa":false,"landing_page_url":"https://doi.org/10.1053/euhj.1998.1093","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2163632142"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059584372","display_name":"Pascal J.M.J Vantrimpont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800290161","display_name":"Montreal Heart Institute","ror":"https://ror.org/03vs03g62","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800290161","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"P Vantrimpont","raw_affiliation_strings":["Section of Cardiology Medical Department, Montreal Heart Institute, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Cardiology Medical Department, Montreal Heart Institute, Canada","institution_ids":["https://openalex.org/I2800290161"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J L Rouleau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J L Rouleau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A Ciampi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Ciampi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"F Harel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Harel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J de Champlain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J de Champlain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"D Bichet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Bichet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"L A Moy\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L A Moy\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M Pfeffer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Pfeffer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059584372"],"corresponding_institution_ids":["https://openalex.org/I2800290161"],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":4.2585,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.9473966,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"10","first_page":"1552","last_page":"1563"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.7465999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.7465999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.0885000005364418,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.04479999840259552,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurohormonal-activation","display_name":"neurohormonal activation","score":0.9610000252723694},{"id":"https://openalex.org/keywords/myocardial-infarction-survivors","display_name":"myocardial infarction survivors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/left-ventricular-dysfunction","display_name":"left ventricular dysfunction","score":0.9810000061988831},{"id":"https://openalex.org/keywords/atrial-natriuretic-peptide","display_name":"atrial natriuretic peptide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/aldosterone","display_name":"aldosterone","score":0.9710000157356262},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.878000020980835},{"id":"https://openalex.org/keywords/epinephrine","display_name":"epinephrine","score":0.8479999899864197},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.8230000138282776},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.675000011920929},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.5400000214576721},{"id":"https://openalex.org/keywords/recurrent-myocardial-infarction","display_name":"reinfarction","score":0.7870000004768372},{"id":"https://openalex.org/keywords/end-systolic-volume","display_name":"end-systolic volume","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8857426047325134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8440021276473999},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7570745944976807},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7517601251602173},{"id":"https://openalex.org/C2910827634","wikidata":"https://www.wikidata.org/wiki/Q1189071","display_name":"Neurohormones","level":3,"score":0.6964260339736938},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.6466569900512695},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6432441473007202},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.636618971824646},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.6006436347961426},{"id":"https://openalex.org/C2777798775","wikidata":"https://www.wikidata.org/wiki/Q207550","display_name":"Infarction","level":3,"score":0.4280718266963959},{"id":"https://openalex.org/C2775846464","wikidata":"https://www.wikidata.org/wiki/Q66360952","display_name":"Brain natriuretic peptide","level":3,"score":0.41685065627098083},{"id":"https://openalex.org/C2778069365","wikidata":"https://www.wikidata.org/wiki/Q78185357","display_name":"Atrial natriuretic peptide","level":2,"score":0.41515377163887024},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.38889336585998535},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33311519026756287},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.2010229229927063},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000450","descriptor_name":"Aldosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009320","descriptor_name":"Atrial Natriuretic Factor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1053/euhj.1998.1093","doi":"https://doi.org/10.1053/euhj.1998.1093","is_oa":false,"landing_page_url":"https://doi.org/10.1053/euhj.1998.1093","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmid:9820995","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9820995","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Clinical Trial"},{"id":"pmh:oai:open-archive.highwire.org:ehj:19/10/1552","doi":null,"is_oa":false,"landing_page_url":"http://eurheartj.oxfordjournals.org/cgi/content/short/19/10/1552","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1967382962","https://openalex.org/W1967720231","https://openalex.org/W1968355808","https://openalex.org/W1984193593","https://openalex.org/W1984575138","https://openalex.org/W1989447605","https://openalex.org/W1995406808","https://openalex.org/W1997062534","https://openalex.org/W2020883986","https://openalex.org/W2021891638","https://openalex.org/W2036770224","https://openalex.org/W2045877680","https://openalex.org/W2048664109","https://openalex.org/W2054141958","https://openalex.org/W2074837834","https://openalex.org/W2076066102","https://openalex.org/W2077477680","https://openalex.org/W2085336412","https://openalex.org/W2148020388","https://openalex.org/W2312388685"],"related_works":["https://openalex.org/W2076066102","https://openalex.org/W2036770224","https://openalex.org/W1968355808","https://openalex.org/W2021891638","https://openalex.org/W2047175553","https://openalex.org/W1967340565","https://openalex.org/W2040312630","https://openalex.org/W2167428145","https://openalex.org/W2162829955","https://openalex.org/W2162887965"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"describe":[2],"the":[3,33,40,113,120,141,167,172,180,204,259,269,279,302,382],"temporal":[4],"evolution":[5],"of":[6,11,39,117,174,271,304,311,330,391],"neurohumoral":[7,34],"activation":[8,310,329,343],"in":[9,32,106,349],"survivors":[10],"myocardial":[12,185,197,316],"infarction":[13,198,317],"with":[14,100,109,124,155,215,230,263,268,351,357,387,405],"left":[15,76,359],"ventricular":[16,77,360],"dysfunction":[17],"who":[18,137],"are":[19],"initially":[20],"asymptomatic":[21,139,368],"and":[22,42,55,65,91,132,164,226,243,278,321,327,332,367,396],"to":[23,26,70,171,179,195,200,209,314,380,399],"relate":[24],"this":[25],"prognosis.":[27,71,354,388],"METHODS":[28],"AND":[29],"RESULTS:":[30],"Patients":[31,99],"substudy":[35],"(n":[36,146],"=":[37,82,147,283,365],"534)":[38],"Survival":[41],"Ventricular":[43],"Enlargement":[44],"(SAVE)":[45],"study":[46],"had":[47,66,74,102],"their":[48],"neurohormones":[49,108,153,242,287,383],"measured":[50,207],"at":[51,374],"baseline,":[52],"3,":[53],"12":[54],"24":[56,115],"months":[57,64,116,144],"post-infarction,":[58,346],"were":[59,166,228,288],"followed":[60],"38":[61],"+/-":[62],"7":[63],"these":[67,107],"values":[68],"related":[69,170,194],"All":[72],"patients":[73,136,350,356],"a":[75,103,234,238,352,358],"ejection":[78,361],"fraction":[79,362],"<":[80,276,319,325,337,363],"or":[81,178,187,199,294,364],"40%":[83,366],"early":[84],"post-infarction.":[85],"Atrial":[86],"natriuretic":[87,162,222,256,372,393],"peptide,":[88,223,394],"aldosterone,":[89,224],"norepinephrine":[90,225,312,397],"plasma":[92,128,160,370],"renin":[93,129],"activity":[94,130],"decreased":[95],"progressively":[96,345],"over":[97],"time.":[98],"events":[101,244],"persistent":[104],"increase":[105],"those":[110],"dying":[111],"within":[112],"first":[114,142],"follow-up":[118],"having":[119],"greatest":[121],"increase.":[122],"Treatment":[123],"captopril":[125],"affected":[126],"only":[127,260,348],"(increase)":[131],"aldosterone":[133,165,331,377,395],"(decrease).":[134],"For":[135],"remained":[138],"for":[140],"3":[143,375],"post-infarction":[145,369],"471),":[148],"by":[149,248,252],"multivariate":[150,253],"analyses":[151,254],"(all":[152],"together":[154],"non-neurohumoral":[156,216],"risk":[157,217],"factors),":[158],"3-month":[159,249],"atrial":[161,221,255,371,392],"peptide":[163,257,373],"most":[168,384,402],"closely":[169,385,403],"development":[173,270],"severe":[175,188,272,333],"heart":[176,189,273,334],"failure":[177,274,335],"combined":[181,280,322],"end-points":[182,281,323],"(cardiovascular":[183],"death,":[184],"infarction,":[186],"failure).":[190],"No":[191],"neurohormone":[192,206,261],"was":[193,212,258,339],"recurrent":[196,315],"cardiovascular":[201],"mortality.":[202],"When":[203],"last":[205],"prior":[208,313],"an":[210,264,307],"event":[211],"considered":[213,289],"along":[214],"factors":[218],"(adjusted":[219],"univariate),":[220],"epinephrine":[227],"associated":[229,262,267,386,404],"prognosis":[231],"indicating":[232],"that":[233,246],"time-dependent":[235],"analysis":[236],"identified":[237,247],"closer":[239],"relationship":[240],"between":[241,309,328],"than":[245],"values.":[250],"However,":[251,285],"event,":[265],"being":[266],"(P":[275,282,318,324,336],"0.001)":[277,320],"0.022).":[284],"when":[286],"as":[290,297],"binary":[291],"variables,":[292],"activated":[293],"non-activated":[295],"(defined":[296],">":[298],"1.96":[299],"SD":[300],"above":[301],"mean":[303],"age-matched":[305],"controls),":[306],"association":[308],"0.01)":[326],"0.05)":[338],"identified.":[340],"CONCLUSIONS:":[341],"Neurohumoral":[342],"decreases":[344],"but":[347],"good":[353],"In":[355],"months,":[376],"levels":[378,390],"appeared":[379],"be":[381,400],"Increased":[389],"appear":[398],"temporally":[401],"events.":[406]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2163632142","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
